Arnsten publications available on PubMed
Memorium:
Arnsten, A.F.T., Patricia Goldman-Rakic: A Remembrance. Neuron 40: 465-470, 2003.
Book Chapters:
Arnsten, A.F.T. and van Dyck, C.H., Monoamine and acetylcholine influences on higher cognitive functions in nonhuman primates: relevance to the treatment of Alzheimer's disease. in Pharmacological Treatment of Alzheimer’s Disease: Molecular and Neurobiological Foundations, J.D. Brioni and M.W. Decker, eds., John Wiley & Sons, New York, pp. 63-86, 1997.
Arnsten, A.F.T., Age-related cognitive deficits and neurotransmitters: The role of catecholamine mechanisms in prefrontal cortical cognitive decline. in Neurodegenerative and Age-Related Changes in Structure and Function of Cerebral Cortex. Cerebral Cortex vol 14, A. Peters and J. Morrison, eds. Plenum Press, New York, N.Y., pp. 89-110, 1999.
Arnsten, A.F.T. and Smith, D. Pharmacological strategies for neuroprotection and rehabilitation following brain trauma. in Cognitive Neurorehabilitation: The Comprehensive Approach. D. Stuss, G. Winocur and I. Robertson, eds., Cambridge University Press, New York, pp 113-135, 1999.
Arnsten, A.F.T., Role of adrenergic receptors in effects of antipsychotic medications on cognition. in Roles of Neurotransmitter Receptors in Actions of Antipsychotic Medications. M. Lidow, ed., CRC Press, New York, pp. 109-120, 2000.
Arnsten, A.F.T., Modulation of prefrontal cortical-striatal circuits: Relevance to therapeutic treatments for Tourette’s Syndrome and Attention Deficit Hyperactivity Disorder, in Proceedings of the Third International Scientific Symposium on Tourette Syndrome. D.J. Cohen and J. Jankovic, eds., Advances in Neurology series, Lippincott, Williams and Wilkins, Philadelphia, PA, pp. 333-342, 2000.
Arnsten, A.F.T., Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex. in The Neuropharmacology of Stimulant Drugs: Implications for AD/HD. M. Solanto, A. Arnsten and F.X. Castellanos, eds., Oxford University Press, New York, NY, pp. 185-208, 2000.
Solanto, M.V., Arnsten, A.F.T., and Castellanos, F.X., The neuroscience of stimulant drug action in ADHD. in The Neuropharmacology of Stimulant Drugs: Implications for AD/HD. M. Solanto, A. Arnsten and F.X. Castellanos, eds., Oxford University Press, New York, NY, pp. 355-380, 2000.
Arnsten, A.F.T. and Castellanos, F.X., Neurobiology of attention regulation and its disorders. in Textbook of Child and Adolescent Psychopharmacology. A. Martin, L. Scahill, D. Charney and J. Leckman, Eds., Oxford University Press, New York, NY, pp. 99-109, 2002.
Arnsten, A.F.T. and Robbins, T.W., Neurochemical modulation of prefrontal cortical function in humans and animals. in The Frontal Lobes. D. Stuss and R. Knight, Eds., Oxford University Press, New York, NY, pp 51-84, 2002.
Arnsten, A.F.T., Molecular pharmacology and the treatment of Tourette’s Syndrome and Attention Deficit-Hyperactivity Disorder. In Neuroscience, Molecular Medicine and the Therapeutic Transformation of Neurology, S.G. Waxman, Ed.. Academic Press, pp. 183-192, 2004.
Southwick, S., Rasmusson, A., Barron, X., Arnsten, A.F.T., Neurobiological and neurocognitive alterations in PTSD. in Neuropsychology of PTSD: Biological, Cognitive and Clinical Perspectives, J.J. Vasterling and C.R. Brewin, eds., Guilford Publications, NY, pp. 27-58, 2005.
Arnsten, A.F.T., Catecholamines and the prefrontal cortical regulation of behaviour and attention. in The Handbook of Attention Deficit Hyperactivity Disorder, edited by M. Bellgrove, M. Fitzgerald and M. Gill; Wiley, New York; pp. 315-329, 2007.
Arnsten, A.F.T., Noradrenergic Actions in prefrontal cortex: Relevance to ADHD, in Attention-Deficit/Hyperactivity Disorder and the Hyperkinetic Syndrome: Current Ideas and Ways Forward, edited by R.D. Oades, Nova Press; pp.109-29, 2006.
